CONTACT: TOM BAUER
109 Technology Innovation Center
Iowa City IA 52242
Biomedical research "spin-off company" to affiliate with
UI Technology Innovation Center
AMES, Iowa -- The State Board of Regents today (Wednesday, March 18)
approved a lease that will enable Goldfinch Diagnostics Inc. of Iowa City
to become a corporate affiliate of the University of Iowa (UI) Technology
Innovation Center (TIC) on the Oakdale Research Campus in Coralville.
The lease of laboratory space is effective Wednesday, April 1.
Goldfinch Diagnostics Inc. is a "spin-off" from UI biomedical
research. The company was established in 1997 to develop diagnostic assays
for infectious diseases. Its current primary project involves the development
of an improved immunodiagnostic test for infection with Trypanosoma
cruzi, a protozoan parasite that lives in the bloodstream. This project,
developed with the help of the Small Business Development Center at the
UI College of Business Administration, is funded by a Small Business Innovation
Research (SBIR) grant from the National Institutes of Health.
The firm's president, Louis V. Kirchhoff of Iowa City, is a professor
of internal medicine in the UI College of Medicine. He received undergraduate
degrees from Harvard University and the University of California at San
Diego and M.D. and M.P.H. degrees from Yale University.
Kirchhoff has worked in the area of infectious diseases research for
more than 15 years. During his 13 years as a faculty member at the UI College
of Medicine, he has been principal investigator on a variety of projects
funded by the federal government, the state of Iowa, and private foundations.
"We are focusing on the development of diagnostics tests based
on genetic engineering techniques to help address infectious disease problems,
particularly in Latin American countries. By affiliating with the TIC,
our new company will have an opportunity to grow and utilize the research
resources of the University." said Kirchhoff.
One of the university's technology transfer programs, the TIC was established
in 1984 to nurture new technology-based business ventures and to encourage
those companies to establish relationships with the UI.
With the addition of Goldfinch Diagnostics, Inc., the TIC will have
16 tenant companies. Some 13 TIC "graduate" firms remain in business
after leaving the incubator.